rs878853002
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000342.4(SLC4A1):c.1825G>A(p.Gly609Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000712 in 1,404,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000342.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC4A1 | NM_000342.4 | c.1825G>A | p.Gly609Arg | missense_variant | 15/20 | ENST00000262418.12 | NP_000333.1 | |
SLC4A1 | XM_005257593.6 | c.1630G>A | p.Gly544Arg | missense_variant | 13/18 | XP_005257650.1 | ||
SLC4A1 | XM_011525130.2 | c.1825G>A | p.Gly609Arg | missense_variant | 15/18 | XP_011523432.1 | ||
SLC4A1 | XM_011525129.3 | c.1800+401G>A | intron_variant | XP_011523431.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC4A1 | ENST00000262418.12 | c.1825G>A | p.Gly609Arg | missense_variant | 15/20 | 1 | NM_000342.4 | ENSP00000262418 | P1 | |
SLC4A1 | ENST00000399246.3 | c.778-51G>A | intron_variant | 5 | ENSP00000382190 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 7.12e-7 AC: 1AN: 1404894Hom.: 0 Cov.: 32 AF XY: 0.00000144 AC XY: 1AN XY: 693232
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 18, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 609 of the SLC4A1 protein (p.Gly609Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant distal renal tubular acidosis (PMID: 14734552, 28638614, 31672324, 32632909, 34159584). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 235293). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC4A1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC4A1 function (PMID: 14734552, 18524859). For these reasons, this variant has been classified as Pathogenic. - |
Autosomal dominant distal renal tubular acidosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Immunology and Genetics Kaiserslautern | Jul 20, 2024 | ACMG Criteria: PP1_S, PP3, PP5, PM2_P, PM1, PS3; Variant was found in heterozygous state - |
Renal tubular acidosis Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Sydney Genome Diagnostics, Children's Hospital Westmead | Dec 20, 2017 | This individual is heterozygous for the c.1825G>A p.(Gly609Arg) variant in the SLC4A1 gene. The variant has not been reported in any population databases (i.e. ExAC, ESP or dbSNP). This variant has been reported in multiple affected individuals within a family with autosomal dominant distal renal tubular acidosis (dRTA, Rungroj et al 2004 J Biol Chem 279:13833-13838). In vitro expression studies showed that this variant did not affect the function of the protein, but resulted in the mislocalisation of the protein (Rungroj et al 2004). This variant is considered to be likely pathogenic according to ACMG guidelines. - |
Southeast Asian ovalocytosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 19, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at